Skip to main content
Top
Published in: Cancer Causes & Control 5/2015

01-05-2015 | Original paper

Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998–2012

Authors: David H. Howard, Florence K. L. Tangka, Janet Royalty, Lucinda P. Dalzell, Jacqueline Miller, Brett O’Hara, Kristy Joseph, Kristy Kenney, Gery Guy, Ingrid J. Hall

Published in: Cancer Causes & Control | Issue 5/2015

Login to get access

Abstract

Objective

To describe the number and proportion of eligible women receiving mammograms funded by the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).

Methods

Low-income, uninsured, and underinsured women aged 40–64 are eligible for mammography screening through the NBCCEDP. We used data from the NBCCEDP, the Current Population Survey, and Medical Expenditure Panel Survey to describe the number and proportion of women screened by the NBCCEDP and overall.

Results

In 2011 and 2012, the NBCCEDP screened 549,043 women aged 40–64, an estimated 10.6 % (90 % confidence interval [CI] 10.4–10.9 %) of the eligible population. We estimate that 30.6 % (90 % CI 26.4–34.8 %) of eligible women aged 40–64 were screened outside the NBCCEDP, and 58.8 % (90 % CI 54.6–63.0 %) were not screened. The proportion of eligible women screened by the NBCCEDP varied across states, with an estimated range of 3.2 % (90 % CI 2.9–3.5 %) to 52.8 % (90 % CI 36.1–69.6 %) and a median of 13.7 % (90 % CI 11.0–16.4 %). The estimated proportion of eligible women aged 40–64 who received mammograms through the NBCCEDP was relatively constant over time, 11.1 % (90 % CI 10.2–11.9 %) in 1998–1999 and 10.6 % (90 % CI 10.4–11.9 %) in 2011–2012 (p = 0.23), even as the number of women screened increased from 343,692 to 549,043.

Conclusions

Although the NBCCEDP provided screening services to over a half million low-income uninsured women for mammography, it served a small percentage of those eligible. The majority of low-income, uninsured women were not screened.
Literature
1.
go back to reference Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 151:727–737PubMedCentralPubMedCrossRef Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 151:727–737PubMedCentralPubMedCrossRef
2.
go back to reference Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM (2008) Disparities in mammography use among US women aged 40–64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care 46:692–700PubMedCrossRef Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM (2008) Disparities in mammography use among US women aged 40–64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care 46:692–700PubMedCrossRef
3.
go back to reference Centers for Disease Control and Prevention (2012) Cancer screening—United States, 2010. MMWR 61:41–46 Centers for Disease Control and Prevention (2012) Cancer screening—United States, 2010. MMWR 61:41–46
4.
go back to reference Finkelstein A, Taubman S, Wright B, Bernstein M, Gruber J, Newhouse JP, Allen H, Baicker K, Oregon Health Study Group (2012) The Oregon health insurance experiment: evidence from the first year. Quart J Econ 127:1057–1106CrossRef Finkelstein A, Taubman S, Wright B, Bernstein M, Gruber J, Newhouse JP, Allen H, Baicker K, Oregon Health Study Group (2012) The Oregon health insurance experiment: evidence from the first year. Quart J Econ 127:1057–1106CrossRef
5.
go back to reference Trivedi AN, Rakowski W, Ayanian JZ (2008) Effect of cost sharing on screening mammography in medicare health plans. N Engl J Med 358:375–383PubMedCrossRef Trivedi AN, Rakowski W, Ayanian JZ (2008) Effect of cost sharing on screening mammography in medicare health plans. N Engl J Med 358:375–383PubMedCrossRef
6.
go back to reference Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, Wethers B, Stokes‐Townsend GA (2014) Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning. Cancer 120(Suppl 16):2540–2548 Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, Wethers B, Stokes‐Townsend GA (2014) Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning. Cancer 120(Suppl 16):2540–2548
7.
go back to reference Tangka FKL, Howard D, Royalty J, Danzell LP, O’Hara B, Miller J, Sabatino S, Joseph K, Guy G, Hall IJ (2014) Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997–2012. Cancer Causes Control (this supplement) Tangka FKL, Howard D, Royalty J, Danzell LP, O’Hara B, Miller J, Sabatino S, Joseph K, Guy G, Hall IJ (2014) Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997–2012. Cancer Causes Control (this supplement)
8.
go back to reference Tangka FKL, Dalaker J, Chattopadhyay SK, Gardner JG, Royalty J, Hall IJ, DeGroff A, Blackman DK, Coates RJ (2006) Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002–2003. Cancer Causes Control 17:1145–1154PubMedCentralPubMedCrossRef Tangka FKL, Dalaker J, Chattopadhyay SK, Gardner JG, Royalty J, Hall IJ, DeGroff A, Blackman DK, Coates RJ (2006) Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002–2003. Cancer Causes Control 17:1145–1154PubMedCentralPubMedCrossRef
14.
go back to reference Howard DH, Richardson LC, Thorpe KE (2009) Cancer screening and age in the United States and Europe. Health Aff 28:1838–1847CrossRef Howard DH, Richardson LC, Thorpe KE (2009) Cancer screening and age in the United States and Europe. Health Aff 28:1838–1847CrossRef
17.
go back to reference Hoerger TJ, Ekwueme DU, Miller JW, Uzunangelov V, Hall IJ, Segel J, Royalty J, Gardner JG, Smith JL, Li C (2011) Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med 40:397–404PubMedCrossRef Hoerger TJ, Ekwueme DU, Miller JW, Uzunangelov V, Hall IJ, Segel J, Royalty J, Gardner JG, Smith JL, Li C (2011) Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med 40:397–404PubMedCrossRef
18.
go back to reference DeNavas-Walt C, Proctor BD, Mills RJ (2004) US Census Bureau Current Population Reports, P60-226, Income, Poverty, and Health Insurance Coverage in the United States: 2003. US Government Printing Office, Washington, DC DeNavas-Walt C, Proctor BD, Mills RJ (2004) US Census Bureau Current Population Reports, P60-226, Income, Poverty, and Health Insurance Coverage in the United States: 2003. US Government Printing Office, Washington, DC
19.
go back to reference Sharpe RE Jr, Levin DC, Parker L, Rao VM (2013) The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography. J Am Coll Radiol 10:21–24PubMedCrossRef Sharpe RE Jr, Levin DC, Parker L, Rao VM (2013) The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography. J Am Coll Radiol 10:21–24PubMedCrossRef
20.
go back to reference Wang AT, Fan J, Van Houten HK, Tilburt JC, Stout NK, Montori VM, Shah ND (2014) Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. PLoS ONE 9:e91399PubMedCentralPubMedCrossRef Wang AT, Fan J, Van Houten HK, Tilburt JC, Stout NK, Montori VM, Shah ND (2014) Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. PLoS ONE 9:e91399PubMedCentralPubMedCrossRef
21.
go back to reference Howard DH, Adams EK (2012) Mammography rates after the 2009 US Preventive Services Task Force breast cancer screening recommendation. Prev Med 55:485–487PubMedCrossRef Howard DH, Adams EK (2012) Mammography rates after the 2009 US Preventive Services Task Force breast cancer screening recommendation. Prev Med 55:485–487PubMedCrossRef
22.
go back to reference Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119:2518–2523PubMedCrossRef Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119:2518–2523PubMedCrossRef
23.
go back to reference White A, Miller J, Royalty J, Ryerson BA, Benard V, Helsel W, Kammerer W (2015). Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009–2012. Cancer Causes Control (this supplement) White A, Miller J, Royalty J, Ryerson BA, Benard V, Helsel W, Kammerer W (2015). Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009–2012. Cancer Causes Control (this supplement)
24.
Metadata
Title
Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998–2012
Authors
David H. Howard
Florence K. L. Tangka
Janet Royalty
Lucinda P. Dalzell
Jacqueline Miller
Brett O’Hara
Kristy Joseph
Kristy Kenney
Gery Guy
Ingrid J. Hall
Publication date
01-05-2015
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 5/2015
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0553-0

Other articles of this Issue 5/2015

Cancer Causes & Control 5/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine